Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial

Ramalho, Dario Brock; Silva, Rosiana Estéfane da; Senna, Maria Camilo Ribeiro de; Moreira, Hugo Silva Assis; Pedras, Mariana Junqueira; Avelar, Daniel Moreira de; Saraiva, Lara; Rabello, Ana; Cota, Gláucia.
Mem. Inst. Oswaldo Cruz ; 113(9): e180200, 2018. tab, graf
Artigo em Inglês | LILACS | ID: biblio-955123

Documentos relacionados

  1. Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial.
  2. Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centre.
  3. Topical liposomal azithromycin in the treatment of acute cutaneous leishmaniasis.
  4. Towards a standard protocol for antimony intralesional infiltration technique for cutaneous leishmaniasis treatment.
  5. Efficacy of Systemic Treatment for Leishmania tropica Cutaneous Leishmaniasis.
  6. Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013).
  7. Using pentamidine to treat cutaneous leishmaniasis in children: a 10-year study in French Guiana.
  8. Efficacy and Tolerability of Miltefosine in the Treatment of Cutaneous Leishmaniasis.
  9. A Randomized, Controlled, Noninferiority, Multicenter Trial of Systemic vs Intralesional Treatment With Meglumine Antimoniate for Cutaneous Leishmaniasis in Brazil.
  10. Safety profile of meglumine antimoniate intralesional infiltration for cutaneous leishmaniasis.